Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
38,126,373
-
Share change
-
+5,133,519
-
Total reported value
-
$2,493,396,132
-
Price per share
-
$65.40
-
Number of holders
-
89
-
Value change
-
+$345,130,853
-
Number of buys
-
59
-
Number of sells
-
32
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2018
As of 31 Mar 2018,
Ascendis Pharma A/S - ADR (ASND) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,126,373 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, FMR LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, Sofinnova Ventures Inc, Vivo Capital, LLC, venBio Select Advisor LLC, EcoR1 Capital, LLC, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.